Four pasture-fed Japanese Black cows showed the main clinical symptoms of severe hemoglobinuria at different periods between 2003 and 2007. Hematological analyses at the first consultation revealed severe anemia, and biochemical analyses indicated both severe hemolysis and disruption of hepatic function. Although the first 2 patients died, the hemoglobinuria and general condition of the remaining 2 cows, who were immediately initiated on large doses of antibiotics, improved within 3 days. Clostridium haemolyticum was detected by polymerase chain reaction (PCR) analysis of the blood sample of 1 of the infected cows. Anti-fascioliasis medicine is administered, and since then, no case of hemoglobinuria has been observed. The cows were diagnosed with bacillary hemoglobinuria, and they represent the first few cases in Japan.
Bacillary hemoglobinuria (BHU; red water disease) in cattle is an acute, toxemic, and highly fatal disease caused by Clostridium haemolyticum; its clinical symptoms are fever, jaundice, and hemoglobinuria [6, 7] . The major toxin produced by C. haemolyticum is a phospholipase C, known as beta-toxin, which possesses hemolytic activity. This beta-toxin causes necrosis of hepatocytes, hemolysis, and damage to capillary endothelium, which lead to hemoglobinuria and loss of vascular fluids in tissues and serous cavities [3] . Although prompt treatment with high doses of specific antibiotics and antitoxic serum is recommended [6, 7] , the illness is of a short course and, in most cases, cattle are found dead in the pasture without prior manifestation of the clinical signs [7] .
The available reports on BHU in cattle are mainly derived from necropsies. Consequently, the sequential changes in the clinical symptoms and the findings of clinico pathologic examinations conducted during the post treatment recovery period may not be well known, even though the disease was first reported in California in 1916 [5] and subsequently in other parts of the world [3] . However, to the best of our knowledge, there is no documented report on either the occurrence of BHU or the isolation of C. haemolyticum from infected cattle in Japan. We report a case of BHU in 1 Japanese Black cow in Japan. We made a diagnosis of BHU by polymerase chain reaction (PCR) detection of the flagellin gene of C. haemolyticum in the blood sample, and the patient recovered completely with the help of antibacterial therapies.
From November 2003, routine visits to the veterinary farm were conducted to assess the condition of a herd of approximately 150 Japanese Black cows in Kagoshima, Japan. All the cows were pasture-fed throughout the year. Case 1, reported in 2004, involved a 20-month-old cow, while case 2, reported in 2006, involved a 3-year-old cow. Both cows presented with the symptoms of anorexia, depression, and excretion of red urine during the observation of the herd in the morning. A detailed clinical examination revealed pyrexia, absence of rumen movement, jaundiced vulval mucous membranes, red wine-like urine, and bloody diarrhea ( Fig. 1 ). Hematological analyses revealed severe anemia [case 1: red blood cells (RBC), 1.18  10 6 /L; white blood cells (WBC), 14.0  10 3 /L; hemoglobin, 6.0 g/dL; packed cell volume (PCV), 3%, and case 2: RBC, 4.33  10 6 /L; WBC, 2.46  10 3 /L; hemoglobin, 8.8 g/dL; PCV, 26%] accompanied by slight leukocytosis. Biochemical analyses indicated severe jaundice [total bilirubin (T-Bil), 23.3 mg/dL in case 1 and 5.0 mg/dL in case 2] and disruption of hepatic function [case 1: aspartate aminotransferase (AST), >1000 U/L; -glutamyl transferase (GGT), 354 U/L and case 2: AST, 278 U/L; GGT, 24 U/L]. The clinical findings in these cases were strongly suggestive of BHU; therefore, diagnostic and treatment procedures were planned so as to control the subsequent occurrence of similar cases.
In December 2006, a 3-year-old Japanese Black nonpregnant cow (case 3), and in June 2007, a 2-year-old Japanese Black non-pregnant cow (case 4) were found exhibiting clinical signs similar to those of the previous cows, except that the body temperature was normal (38.5C) in case 3. On the basis of the clinical symptoms, a tentative diagnosis of BHU was made. The patients were adminis-tered a high dose of cefazolin [10 mg/kg intravenously (i.v.)] every 24 hr and ampicillin [10 mg/kg intramuscularly (i.m.)] every 12 hr for 3 days. Ringer's solution (1 L), 25% glucose (1 L), fursultiamine hydrochloride (500 mg), tranexamic acid (10 mg/kg), and nutritional drugs for the improvement of hepatic function were concurrently administered. Besides this, blood samples were collected on posttreatment days 2 and 5. On posttreatment day 6, patient 3 received a blood transfusion (2.5 L). In case 4, blood tests were performed on days 2, 3, 4, 7, 11, and 14, the results of which are shown in Tables 1 and 2. In case 3, although the PCV and hemoglobin levels were observed to decrease continuously during the sampling period, an improvement in the hepatic parameters (T-Bil, AST, and GGT) was observed only on posttreatment day 5. Additionally, by day 5, recovery of appetite, resumption of rumen movements, and normal urine color and normal feces were observed. On day 17, patient 3 seemed to have completely recovered from the illness. In case 4, continuous decrease in the PCV and hemoglobin levels, which is reflective of hemolysis, was observed until posttreatment day 7. However, from day 2, clinical improvements such as the recovery of appetite, resumption of rumen movements, and normal urine color and normal feces were observed, accompanied with an improvement in the blood parameters. Changes in the status of haemoglobinuria after the treatment are shown in Fig. 2 . Hemolysis disappeared on posttreatment day 7; thereafter, the cow seemed to have completely recovered from the clinical conditions. In addition, the urine sample collected on day 1 was subjected to PCR analysis for the diagnosis of leptospirosis in both cases, but negative results were obtained. These 4 cases of BHU necessitated the routine administration of the oral anti fascioliasis medicine triclabendazole (Fasinex; Novartis) to the entire herd after every 6 months and, consequently, no BHU cases have been observed at the farm to date.
C. haemolyticum detection in the blood samples of patient 3 and 4 was conducted by using the PCR system based on the flagellin gene (fliC) sequence (DDBJ accession no. AB058939) reported by Sasaki et al. [8] . The sample from patient 3 was collected before initiation of the treatment, i.e. after the onset of the disease, but the sample from patient 4 was collected 1 day after the onset. Bands were obtained for both the whole blood and serum samples (lanes 1 and 2, respectively; Fig. 3 ) of patient 3, but not for the whole blood sample of patient 4 (data not shown); the absence of the band for patient 4 may be attributable to the antibiotic injection administered by the farm staff before the blood sample was collected. The presence of the fliC gene was also confirmed by nested PCR using the forward primer 5- . This result demonstrated that patient 3 was infected with C. haemolyticum and, hence, the diagnosis of BHU was established. Blood samples from both patients were inoculated onto blood agar plates for the cultivation of aerobic or anaerobic organisms. We were unable to isolate the bacteria, probably because they were fastidious. In case 4, this may also be explained by the ampicillin treatment administered 1 day before the blood sampling.
Previously, the clinical diagnosis of BHU was mainly made after excluding postparturient hemoglobinuria and other causes of hemoglobinuria, such as acute leptospirosis, babesiosis, and anaplasmosis, and hemolytic anemia caused by cruciferous plants [6, 7] . In the present study, leptospiro-sis was excluded as a possible diagnosis on the basis of a serologic test conducted with the serum samples and PCR analysis using the urine samples. The next step was microbiological analysis for detecting C. haemolyticum in the blood samples. It has been reported that isolation of C. haemolyticum is time-consuming and very difficult, since it requires strict anaerobic conditions, and that clinical specimens are often contaminated with other anaerobic bacteria, including environmental clostridia from soil, which grow faster than the pathogenic bacteria in the culture medium [9, 11] . Recently, Sasaki et al. [8] reported the possibility of rapid identification of pathogenic clostridia with the help of the established multiplex PCR system. We definitively diagnosed patient 3 with BHU on the basis of the PCR and sequencing results. The combination of the PCR findings and typical clinical symptoms observed in the other 3 cases (cases 1, 2, and 4) may be indicative of BHU.
It has been reported that under natural conditions in endemic areas, bacterial invasion originates in the alimentary tract after the ingestion of contaminated material, and that telangiectasis, necrobacillosis, and fascioliasis are the (Table 1) . ND: Not determined.
triggering factors that create local anaerobic conditions for the germination of dormant spores [6, 7, 12] . The diagnosis of fascioliasis and the prevention of the occurrence of BHU after the administration of anti fascioliasis medication suggests that fascioliasis may have been an initiating factor for BHU on this farm. Further, the presence of C. haemolyticum in the liver and kidneys of healthy cattle have been reported [10] . Although vaccinations against clostridium infections are carried out worldwide [4] , there are no vaccines for C. haemolyticum infection in Japan. Therefore, the present study indicated the efficacy of anti fascioliasis therapy in preventing BHU in fascioliasis-contaminated pastures.
Although the clinical course of BHU is rapid and the outcome is almost invariably fatal [2, 13] , successful treatment of the disease in its early stages by the administration of a large dose of specific antibiotics such as procaine penicillin, and tetracycline, and antitoxic serum, if available, has been reported [1, 6, 7] . For recovery from BHU, it is critical for the dose and route of administration of antibiotics at the first treatment to achieve a blood concentration of the antibiotic that is effective against C. haemolyticum. This is supported by the fact that the 2 patients (patients 3 and 4) who were administered high doses of antibiotics both intravenously and intramuscularly in the initial stage recovered rapidly from the condition. The present study also provides a possible therapeutic protocol for BHU without the use of the antitoxic serum.
To our knowledge, this is the first report on the diagnosis of BHU caused by C. haemolyticum infection in a Japanese Black cow, where the diagnosis was confirmed by PCR analysis and the patient completely recovered after antibacterial therapy. The PCR technique may be useful for rapid and accurate detection of C. haemolyticum derived from the whole blood or serum samples of suspected BHU patients.
